SAMD8

SAMD8 (SMSr) is an ER-resident lipid-metabolizing enzyme that functions as both a ceramide phosphoethanolamine (CPE) synthase and a broad-specificity phospholipase C, with its phosphatidylethanolamine phospholipase C (PE-PLC) activity being kinetically dominant over CPE synthesis (PMID:19506037, PMID:33621517, PMID:34332077). The cytoplasmic N-terminal SAM domain drives homotypic oligomerization into trimers and hexamers that are required for ER retention and ceramide homeostasis; disruption of oligomerization or catalytic activity causes ER ceramide accumulation and mislocalization to mitochondria, triggering the mitochondrial apoptotic pathway (PMID:24259670, PMID:28120887). The SAM domain also mediates physical interaction with DGKδ and DGKζ, channeling DAG produced by SMSr into phosphatidic acid signaling, and SMSr interacts with the serine palmitoyltransferase subunit SPTLC2 to positively regulate de novo sphingolipid biosynthesis (PMID:31980461, PMID:37166445, PMID:40998032). In vivo, SMSr PE-PLC activity promotes nonalcoholic fatty liver disease progression by reducing PE levels and enabling nuclear β-catenin signaling, and SMSr is a caspase-6 substrate during apoptosis (PMID:37586586, PMID:28659495).

1. 2009 High

   The identity of SMSr/SAMD8 as a monofunctional CPE synthase—distinct from SMS1/SMS2—resolved what enzymatic activity the gene encodes and showed that its catalytic disruption causes ER ceramide accumulation and ER exit-site collapse.

   Evidence Heterologous expression, in vitro enzymatic assays with radiolabeled substrates, catalytic mutant analysis, confocal microscopy in HeLa cells

   PMID:19454763 PMID:19506037

   Open questions at the time

   • Mechanism by which ceramide accumulates upon catalytic inactivation remained unclear given low CPE flux
   • In vivo relevance of the ER exit-site phenotype not tested
   • No structural basis for head-group selectivity
2. 2013 High

   Establishing that SMSr suppresses ceramide-induced mitochondrial apoptosis linked ER ceramide homeostasis to cell survival and revealed that the SAM domain contributes to ceramide control independently of CPE production.

   Evidence siRNA knockdown, catalytic mutants, caspase activation and cytochrome c release assays, lipid MS, rescue with ceramide synthesis inhibitors and mitochondria-targeted bacterial ceramidase

   PMID:24259670

   Open questions at the time

   • Whether ceramide itself translocates to mitochondria or signals indirectly was not resolved
   • SAM domain mechanism of action in ceramide control remained undefined
3. 2015 High

   Mouse knockout studies unexpectedly showed that SMSr loss does not significantly affect ceramide levels or secretory pathway integrity in vivo, challenging the cell-culture ceramide-accumulation model and establishing SMSr as the principal brain CPE synthase.

   Evidence SMSr KO and SMS2 KO mice, tissue-specific lipid mass spectrometry, histology

   PMID:25667419

   Open questions at the time

   • Discrepancy between acute cell-culture and chronic in vivo phenotypes not mechanistically explained
   • Compensatory mechanisms in KO mice not identified
4. 2017 High

   Demonstration that SAM domain-mediated homotypic oligomerization (trimers/hexamers) controls ER retention of SMSr explained how the SAM domain contributes to function beyond catalysis, and identification of a single active-site residue (Glu vs. Asp) governing CPE vs. SM selectivity defined the structural basis of substrate specificity.

   Evidence Chemical crosslinking, co-IP, native gel, confocal microscopy, site-directed mutagenesis, single-molecule photobleaching, domain-swap enzymatic assays

   PMID:27729449 PMID:28120887 PMID:28336574

   Open questions at the time

   • High-resolution structure of SMSr oligomers not determined
   • How oligomerization state responds to ceramide flux mechanistically is unclear
5. 2017 High

   Identification of SMSr as a specific caspase-6 substrate revealed that the protein is actively dismantled during apoptosis, potentially disrupting its ceramide-regulatory function as part of the apoptotic program.

   Evidence Cell-free reconstitution with purified caspases, caspase-specific inhibitors, siRNA knockdown, staurosporine/FasL-induced apoptosis

   PMID:28659495

   Open questions at the time

   • Functional consequence of caspase-6 cleavage on ceramide homeostasis or CPE production not directly measured
   • Whether cleavage is required for apoptosis progression or is a downstream event is unknown
6. 2020 High

   Physical interaction between the SAM domains of SMSr and DGKδ, and stimulation of DGKδ activity by SMSr, established a mechanism by which SMSr-generated DAG is channeled into phosphatidic acid signaling with acyl-chain specificity.

   Evidence Co-immunoprecipitation, LC-MS/MS lipidomics, in vitro DGK activity assay, deletion mutant analysis in HEK293 cells

   PMID:31980461

   Open questions at the time

   • Whether the SMSr–DGKδ complex forms constitutively or is regulated is unknown
   • Stoichiometry and topology of the heteromeric SAM complex not resolved
7. 2021 High

   Discovery that purified SMSr possesses robust PE-PLC, PI-PLC, and PAP activities—orders of magnitude faster than CPE synthesis—reframed the enzyme as a multi-substrate phospholipase C rather than primarily a CPE synthase.

   Evidence Highly purified recombinant SMSr, in vitro enzymatic assays with multiple phospholipid substrates, pharmacological inhibition, lipidomics in COS-7 cells and in vivo adenoviral overexpression

   PMID:33621517 PMID:34332077

   Open questions at the time

   • Relative contribution of PE-PLC vs. CPE synthase activity in physiological ER membranes not quantified
   • Whether accessory subunits or ER lipid environment modulates substrate preference is untested
8. 2023 High

   In vivo demonstration that SMSr PE-PLC activity drives NAFLD/NASH via PE depletion and consequent nuclear β-catenin signaling provided the first disease-level physiological role for SMSr's phospholipase activity, and extended the SAM-mediated interaction network to DGKζ.

   Evidence Smsr KO mice on high-fat diet/fructose, triple KO mice, PE supplementation rescue, β-catenin nuclear fractionation, co-IP with DGKζ deletion mutants

   PMID:37166445 PMID:37586586

   Open questions at the time

   • Whether PE reduction acts directly on β-catenin or through intermediate signaling is unresolved
   • DGKζ interaction lacks reciprocal validation and in vitro reconstitution
9. 2025 Medium

   Physical interaction of SMSr with the serine palmitoyltransferase subunit SPTLC2, and positive regulation of SPT activity by SMSr, established a feedback link between SMSr and de novo sphingolipid biosynthesis modulated by PE levels.

   Evidence Co-immunoprecipitation of SMSr–SPTLC2, SPT activity assay in liver microsomes, Smsr KO and overexpression, PE supplementation reversal

   PMID:40998032

   Open questions at the time

   • Single-lab co-IP without reciprocal tagged pulldown or in vitro reconstitution
   • Whether the interaction is direct or mediated through a complex is unknown
   • Mechanism by which PE reverses SPTLC2 upregulation is not defined

• Major open questions include: the high-resolution structure of SMSr oligomers and heteromeric SAM complexes; how the enzyme's multiple catalytic activities are partitioned in native ER membranes; the molecular basis of the discrepancy between acute cell-culture ceramide phenotypes and chronic in vivo tolerance of SMSr loss; and the physiological significance of caspase-6 cleavage.
• No high-resolution structure of SMSr or its SAM oligomers
• Relative in vivo flux through PE-PLC vs CPE synthase activities not determined
• Mechanism reconciling cell-culture ceramide accumulation with normal ceramide in KO mice unresolved